Clover Health Investments Co (CLOV) Smart Money Holdings (13F, Q2 2026)

CLOV ranks #2685 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

230 institutions disclose a position in CLOV, but none treat it as a major bet — even Gmt Capital CORP, its most concentrated holder, allocates just 0.4% of its own portfolio to it.

CLOV is down 4.3% today, but institutions show net buying of $280.6M this quarter — a divergence between today's price move and the underlying institutional flow.

CLOV posted net income of $20.4M over the trailing twelve months, and currently trades at a P/E of 112.5.

• Profitable — net income of $20.4M over the trailing twelve months
• Revenue grew 54.0% year over year
• Net income improved year over year, from -$13.6M to $20.4M
• Operating cash flow was negative, using $66.9M in cash
• Current ratio of 1.47x — below the conventional 1.5x liquidity buffer
• Liabilities run 0.75x equity — within a conventional range